4th Quarter - Amendment
RESOLUTE-DC for MODEL MEDICINES
Firm
Client
Income
—
Expenses
—
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (No Activity) | Dec 31, 2023 | — | Replaced |
| 4th Quarter - Amendment (this page) | Jan 19, 2024 | — | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Introduce Model Medicines and how the company is innovating at the intersection of data science, biology and drug development.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM WILCZEWSKI | Chief of Staff, International Trade Administration |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.